Central Pharmaceuticals (DHA:CENTRALPHL) Price-to-Operating-Cash-Flow : (As of May. 01, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Central Pharmaceuticals Price-to-Operating-Cash-Flow?

As of today (2024-05-01), Central Pharmaceuticals's share price is BDT23.70. Central Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2022 was BDT-0.01. Hence, Central Pharmaceuticals's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Central Pharmaceuticals's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 11 years, Central Pharmaceuticals's highest Price-to-Operating-Cash-Flow Ratio was 2087.50. The lowest was 12.57. And the median was 127.66.

DHA:CENTRALPHL's Price-to-Operating-Cash-Flow is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 17.63
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Central Pharmaceuticals's Cash Flow from Operations per share for the three months ended in Sep. 2022 was BDT0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2022 was BDT-0.01.

During the past 11 years, Central Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was -35.40% per year. The lowest was -60.20% per year. And the median was -43.10% per year.

Central Pharmaceuticals Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Central Pharmaceuticals's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Central Pharmaceuticals Price-to-Operating-Cash-Flow Chart

Central Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

146.51

880.00

Central Pharmaceuticals Quarterly Data
	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Jun23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	165.22	-	-	-

Competitive Comparison of Central Pharmaceuticals's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Central Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Central Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Central Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Central Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.

Central Pharmaceuticals Price-to-Operating-Cash-Flow Calculation

Central Pharmaceuticals's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	23.70	/	-0.009
	=

Central Pharmaceuticals's Share Price of today is BDT23.70.
Central Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT-0.01.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Central Pharmaceuticals Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Central Pharmaceuticals's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Central Pharmaceuticals (DHA:CENTRALPHL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Central Pharmaceuticals Ltd (DHA:CENTRALPHL) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

South West Darus Salam Road, 2-A/1, 2nd Floor, Mirpur - 1, Dhaka, BGD, 1216

Website

https://www.centralphl.com

Central Pharmaceuticals Ltd is engaged in the manufacturing and marketing of medicines in Bangladesh. The company manufactures finished formulation products for general people, hospitals, clinics, government organizations, corporations, and other non-government organizations. Its product portfolio encompasses therapeutic categories including gastrointestinal, anti-infective, vitamins and minerals, allergy cough and cold, analgesic and musculoskeletal, dermatological, oral rehydration salt, and others. The products are in the dosage forms of tablets, capsules, liquid, and ointments.

Central Pharmaceuticals (DHA:CENTRALPHL) Headlines

No Headlines